ID: ALA3809105

Max Phase: Preclinical

Molecular Formula: C26H29F7N4O4

Molecular Weight: 594.53

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)(O)CNC(=O)Nc1ccc(C(=O)N2CCN(Cc3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)CC2)cc1F

Standard InChI:  InChI=1S/C26H29F7N4O4/c1-23(2,40)15-34-22(39)35-20-8-5-17(13-19(20)27)21(38)37-11-9-36(10-12-37)14-16-3-6-18(7-4-16)24(41,25(28,29)30)26(31,32)33/h3-8,13,40-41H,9-12,14-15H2,1-2H3,(H2,34,35,39)

Standard InChI Key:  FQDWDKZDYQQCGX-UHFFFAOYSA-N

Associated Targets(non-human)

Rhesus monkey 3147 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cynomolgus monkey 4946 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 594.53Molecular Weight (Monoisotopic): 594.2077AlogP: 3.99#Rotatable Bonds: 7
Polar Surface Area: 105.14Molecular Species: NEUTRALHBA: 5HBD: 4
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.47CX Basic pKa: 6.51CX LogP: 2.97CX LogD: 2.89
Aromatic Rings: 2Heavy Atoms: 41QED Weighted: 0.36Np Likeness Score: -1.44

References

1. Stachel SJ, Zerbinatti C, Rudd MT, Cosden M, Suon S, Nanda KK, Wessner K, DiMuzio J, Maxwell J, Wu Z, Uslaner JM, Michener MS, Szczerba P, Brnardic E, Rada V, Kim Y, Meissner R, Wuelfing P, Yuan Y, Ballard J, Holahan M, Klein DJ, Lu J, Fradera X, Parthasarathy G, Uebele VN, Chen Z, Li Y, Li J, Cooke AJ, Bennett DJ, Bilodeau MT, Renger J..  (2016)  Identification and in Vivo Evaluation of Liver X Receptor β-Selective Agonists for the Potential Treatment of Alzheimer's Disease.,  59  (7): [PMID:27011007] [10.1021/acs.jmedchem.6b00176]

Source